Search Results - "Muenchmeier, Niklas"

Nuclear transfer nTreg model reveals fate-determining TCR-β and novel peripheral nTreg precursors by Ku, Manching, Chang, Shih-En, Hernandez, Julio, Abadejos, Justin R., Sabouri-Ghomi, Mohsen, Muenchmeier, Niklas J., Schwarz, Anna, Valencia, Anna M., Kirak, Oktay

“…To study the development and function of “natural-arising” T regulatory (nTreg) cells, we developed a novel nTreg model on pure nonobese diabetic background…”
Get full text

A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy by Muenchmeier, Niklas, Boecker, Sophia, Bankel, Lorenz, Hinz, Laura, Rieth, Nicole, Lapa, Constantin, Mendler, Anna N, Noessner, Elfriede, Mocikat, Ralph, Nelson, Peter J

“…Cellular therapy is a promising therapeutic strategy for malignant diseases. The efficacy of this therapy can be limited by poor infiltration of the tumor by…”
Get full text

Nuclear transfer nTreg model reveals fate-determining TCR-[Beta] and novel peripheral nTreg precursors by Ku, Manching, Chang, Shih-En, Hernandez, Julio, Abadejos, Justin R, Sabouri-Ghomi, Mohsen, Muenchmeier, Niklas J, Schwarz, Anna, Valencia, Anna M, Kirak, Oktay

“…To study the development and function of "natural-arising" T regulatory (nTreg) cells, we developed a novel nTreg model on pure nonobese diabetic background…”
Get full text

Membrane-anchored chemokine fusion proteins: A novel class of adjuvants for immunotherapy by Nelson, Peter J, Muenchmeier, Niklas

“…Adoptive or active cancer immunotherapy can fail owing to the inefficient recruitment of effector leukocytes to malignant lesions. The intratumoral injection…”
Get full text

A multicenter retrospective evaluation of Chronic Myeloid Leukemia (CML) therapy in Austria assessing the impact of early treatment response on patient outcomes in a real-life setting: R-EFECT study by Petzer, Andreas L., Sperr, Wolfgang R., Buxhofer-Ausch, Veronika, Sliwa, Thamer, Schmidt, Stefan, Greil, Richard, Wölfler, Albert, Pichler, Petra, Dormann, Clemens, Burgstaller, Sonja, Tinchon, Christoph, Lang, Alois, Goebel, Florian, Uthman, Shanow, Muenchmeier, Niklas, Valent, Peter

“…Summary Background Several clinical trials in chronic phase (CP) chronic myeloid leukemia (CML) showed that early response to tyrosine kinase inhibitor (TKI)…”
Get full text

Human Renal Cell Carcinoma Induces a Dendritic Cell Subset That Uses T-Cell Crosstalk for Tumor-Permissive Milieu Alterations by Figel, Ainhoa-M, Brech, Dorothee, Prinz, Petra U, Lettenmeyer, Ulrike K, Eckl, Judith, Turqueti-Neves, Adriana, Mysliwietz, Josef, Anz, David, Rieth, Nicole, Muenchmeier, Niklas, Buchner, Alexander, Porubsky, Stefan, Siegert, Sabine I, Segerer, Stephan, Nelson, Peter J, Noessner, Elfriede

“…Tissue dendritic cells (DCs) may influence the progression of renal cell carcinoma (RCC) by regulating the functional capacity of antitumor effector cells. DCs…”
Get full text

SDF‐1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization by Stachel, Georg, Trenkwalder, Teresa, Götz, Franziska, El Aouni, Chiraz, Muenchmeier, Niklas, Pfosser, Achim, Nussbaum, Claudia, Sperandio, Markus, Hatzopoulos, Antonis K., Hinkel, Rabea, Nelson, Peter J., Kupatt, Christian

“…ABSTRACT The facilitated recruitment of vascular progenitor cells (VPCs) to ischemic areas might be a therapeutic target for neovascularization and repair…”
Get full text

A novel CXCL8 protein-based antagonist in acute experimental renal allograft damage by Bedke, Jens, Nelson, Peter J., Kiss, Eva, Muenchmeier, Niklas, Rek, Angelika, Behnes, Carl-Ludwig, Gretz, Norbert, Kungl, Andreas J., Gröne, Hermann-Josef

“…Acute renal allograft damage is caused by early leukocyte infiltration which is mediated in part by chemokines presented by glycosaminoglycan (GAG) structures…”
Get full text

Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma: Implications for Therapeutic Cell Transfer by PRZEWOZNIK, Margarethe, HÖMBERG, Nadine, MOCIKAT, Ralph, NAUJOKS, Marcella, PÖTZL, Johann, MÜNCHMEIER, Niklas, BRENNER, Christoph D, ANZ, David, BOURQUIN, Carole, NELSON, Peter J, RÖCKEN, Martin

“…During inflammation and in transplantable tumor models, natural killer (NK) cells are recruited to pathologic tissues and activated to produce proinflammatory…”
Get full text

Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice by Raggi, Matthias C, Djafarzadeh, Roghieh, Muenchmeier, Niklas, Hofstetter, Monika, Jahn, Birgit, Rieth, Nicole, Nelson, Peter J

“…Exogenous application of recombinant TIMP-1 protein modified by addition of a glycosylphosphatidylinositol (GPI) anchor allows efficient insertion of the…”
Get more information